Research / FCUV / Fundamental state Inspectable configuration
State dimensions Filing 0001683168-23-002065 General Corporate
Capex intensity 76th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.capex_revenue_ratio
11.93% · OPTIONAL · VALID
Operating cash generation 15th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-836.49% · OPTIONAL · VALID
Revenue growth 5th Own-history percentile · N=19
Evidence method Yoy · gp.fundamentals.revenue
-75.35% · CORE · VALID
Inventory pressure 70th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
29.35% · OPTIONAL · VALID
Gross margin 10th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
6.42% · CORE · VALID
Operating margin 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
-1472.11% · CORE · VALID
R&D intensity 95th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
299.87% · OPTIONAL · VALID
SBC intensity 12th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.00% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 38 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/7 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/7 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 7/7 normalized Level 3 Mar 31, 2026 6/6 normalized Level 3 Jun 30, 2026 5/6 normalized Level 4 Period transition
What moved in the state? Capex Intensity Increased
Previous -0.84%
Current 11.93%
Delta 12.77% Cash Generation Increased
Previous -1130.45%
Current -836.49%
Delta 293.96% Growth Increased
Previous -90.44%
Current -75.35%
Delta 15.10% Inventory Pressure Decreased
Previous 80.97%
Current 29.35%
Delta -51.62% Margin Decreased
Previous 30.03%
Current 6.42%
Delta -23.60% Profitability Increased
Previous -1605.77%
Current -1472.11%
Delta 133.67% R And D Intensity Increased
Previous 219.46%
Current 299.87%
Delta 80.41% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.